Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients. The discovery gives…

Transferring the gut microbes from a mouse with colon tumors to germ-free mice makes those mice prone to getting tumors as well, according to the results of a…

A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant…

A pilot initiative conducted at Mount Sinai Hospital offers compelling evidence that establishing standardized criteria for calling a palliative care consultation improves the quality of care for…

Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds…

A type of HIV medicine that stops the AIDS virus from entering immune system cells could in future be put to work against cancer in new combination therapies…

Doctors seldom tell patients about the possible harms of getting screened for cancer, a new study shows.

During any screening test, there is a chance of so-called overdiagnosis - finding…

An ethically dubious medical research study from the 1950s and 60s, known as the “Bowery series,” foreshadowed and shared commonalities with prostate cancer screening and…

The air we breathe is laced with cancer-causing substances and is being officially classified as carcinogenic to humans, the World Health Organization’s cancer agency said on Thursday.

Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching ‘on’ death pathways in cancer cells. The peptide remains…

A class of molecules called microRNAs may offer cancer patients two ways to combat their disease.

Researchers at Princeton University have found that microRNAs - small bits of genetic…

A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make…

Cancer immunotherapy can successfully use the body’s own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical…

A chemical found in red wine remains effective at fighting cancer even after the body’s metabolism has converted it into other compounds.

This is an…

In 2006 when doctors started testing a melanoma treatment made by Roche Holding AG on patients, they were used to facing slim odds - about one in eight…

Married cancer patients are less likely to die of their disease than those who aren’t wed, a new study suggests.

The study, of more than 730,000 people who…

Researchers at Lund University have unexpectedly discovered that an old cancer drug can be used to prevent rejection of transplanted tissue. The researchers now have high hopes that their discovery could…

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information…

Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new…

When a child is diagnosed with cancer, one of the first questions the parents ask is “Will my other children get cancer?” A new study from…

The results of a large-scale analysis of the association between DNA viruses and human malignancies suggest that many of the most common cancers are not associated with DNA viruses.…

St. Jude Children’s Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing…

Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace…

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure…

Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4. Each of these antibodies binds to…